Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy

Redox Biology

Volumn 4, Issue , 2015, Pages 184-192

  Poillet Perez, Laura ^a   Despouy, Gilles ^a   Delage Mourroux, Régis ^a   Boyer Guittaut, Michaël ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Antioxidant; Autophagy; Cancer; Mitochondria; Mitophagy; ROS

Indexed keywords

3 METHYLADENINE; ACETYLCYSTEINE; ADENYLATE KINASE; ARTEMISININ; AUTOPHAGY PROTEIN 5; BECLIN 1; CARNOSOL; CD11B ANTIGEN; CICLOPIROXOLAMINE; CRYOPYRIN; GLUTATHIONE PEROXIDASE; HIGH MOBILITY GROUP B1 PROTEIN; HONOKIOL; HYDROXYCHLOROQUINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P62; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SUPEROXIDE DISMUTASE; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2; UNINDEXED DRUG; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; ATG4A PROTEIN, HUMAN; AUTOPHAGY RELATED PROTEIN; BECN1 PROTEIN, HUMAN; CYSTEINE PROTEINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; KEAP1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; SERINE THREONINE PROTEIN KINASE ULK1; SIGNAL PEPTIDE; ULK1 PROTEIN, HUMAN;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CANCER CELL LINE; CANCER CHEMOTHERAPY; CANCER GROWTH; CARCINOGENESIS; CELL DEATH; CELL INTERACTION; CELL PROTECTION; CELL SURVIVAL; CELL TRANSFORMATION; DRUG ACTIVITY; ELECTRON SPIN RESONANCE; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; LYSOSOME; MALIGNANT TRANSFORMATION; METASTASIS; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MITOPHAGY; NONHUMAN; OXIDATIVE STRESS; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; STROMA CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE METASTASIS; METABOLISM; NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN-1 HOMOLOG; AUTOPHAGY-RELATED PROTEINS; BECLIN-1; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; LYMPHATIC METASTASIS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84920971375     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.12.003     Document Type: Review

References (135)

1. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annual Review of Genetics 2009, 43:67-93. http://www.ncbi.nlm.nih.gov/pubmed/19653858, 10.1146/annurev-genet-102808-114910.
2. Dunlop E.A., Tee A.R. mTOR and autophagy: a dynamic relationship governed by nutrients and energy. Seminars in Cell and Developmental Biology 2014, 36C:121-129. http://www.ncbi.nlm.nih.gov/pubmed/25158238, 10.1016/j.semcdb.2014.08.006.
3. Weidberg H., Shvets E., Elazar Z. Biogenesis and cargo selectivity of autophagosomes. Annual Review of Biochemistry 2011, 80:125-156. http://www.ncbi.nlm.nih.gov/pubmed/21548784, 10.1146/annurev-biochem-052709-094552.
4. Pankiv S., et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. Journal of Biological Chemistry 2007, 282(33):24131-24145. http://www.ncbi.nlm.nih.gov/pubmed/17580304, 10.1074/jbc.M702824200.
5. Kirkin V., et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Molecular Cell 2009, 33(4):505-516. http://www.ncbi.nlm.nih.gov/pubmed/19250911, 10.1016/j.molcel.2009.01.020.
6. Rozenknop A., et al. Characterization of the interaction of GABARAPL-1 with the LIR motif of NBR1. Journal of Molecular Biology 2011, 410(3):477-487. http://www.ncbi.nlm.nih.gov/pubmed/21620860, 10.1016/j.jmb.2011.05.003.
7. Novak I., et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Reports 2010, 11(1):45-51. http://www.ncbi.nlm.nih.gov/pubmed/20010802, 10.1038/embor.2009.256.
8. Lemasters J.J. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Research 2005, 8(1):3-5. http://www.ncbi.nlm.nih.gov/pubmed/15798367, 10.1089/rej.2005.8.3.
9. Choi A.M., Ryter S.W., Levine B. Autophagy in human health and disease. New England Journal ofMedicine 2013, 368(19):1845-1846. http://www.ncbi.nlm.nih.gov/pubmed/23656658, 10.1056/NEJMc1303158.
10. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nature Reviews Cancer 2012, 12(6):401-410. http://www.ncbi.nlm.nih.gov/pubmed/22534666, 10.1038/nrc3262.
11. Ávalos Y., et al. Tumor suppression and promotion by autophagy. BioMed Research International 2014, 2014:603980. http://www.ncbi.nlm.nih.gov/pubmed/25328887, 10.1155/2014/603980.
12. Kenific C.M., Debnath J. Cellular and metabolic functions for autophagy in cancer cells. Trends in Cell Biology 2014, http://www.ncbi.nlm.nih.gov/pubmed/25278333, 10.1016/j.tcb.2014.09.001.
13. Gough D.R., Cotter T.G. Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death and Disease 2011, 2:e213. http://www.ncbi.nlm.nih.gov/pubmed/21975295, 10.1038/cddis.2011.96.
14. Cross C.E., et al. Oxygen radicals and human disease. Annals of Internal Medicine 1987, 107(4):526-545. http://www.ncbi.nlm.nih.gov/pubmed/3307585.
15. St-Pierre J., et al. Topology of superoxide production from different sites in the mitochondrial electron transport chain. Journal of Biological Chemistry 2002, 277(47):44784-44790. http://www.ncbi.nlm.nih.gov/pubmed/12237311, 10.1074/jbc.M207217200.
16. Murphy M.P. How mitochondria produce reactive oxygen species. Biochemistry Journal 2009, 417(1):1-13. http://www.ncbi.nlm.nih.gov/pubmed/19061483, 10.1042/BJ20081386.
17. Poli G., et al. Oxidative stress and cell signalling. Current Med. Chem. 2004, 11(9):1163-1182. 10.2174/0929867043365323.
18. Fruehauf J.P., Meyskens F.L. Reactive oxygen species: a breath of life or death?. Clinical Cancer Research 2007, 13(3):789-794. http://www.ncbi.nlm.nih.gov/pubmed/17289868, 10.1158/1078-0432.CCR-06-2082.
19. Vendramini-Costa D.B., Carvalho J.E. Molecular link mechanisms between inflammation and cancer. Current Pharmaceutical Design 2012, 18(26):3831-3852. http://www.ncbi.nlm.nih.gov/pubmed/22632748.
20. Scherz-Shouval R., et al. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO Journal 2007, 26(7):1749-1760.
21. Inoki K., Zhu T., Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115(5):577-590.
22. Gwinn D.M., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Molecular Cell 2008, 30(2):214-226. http://www.ncbi.nlm.nih.gov/pubmed/18439900, 10.1016/j.molcel.2008.03.003.
23. Kim J., et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biology 2011, 13(2):132-141. http://www.ncbi.nlm.nih.gov/pubmed/21258367, 10.1038/ncb2152.
24. Egan D.F., et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011, 331(6016):456-461. http://www.ncbi.nlm.nih.gov/pubmed/21205641, 10.1126/science.1196371.
25. Egan D., et al. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 2011, 7(6):643-644. http://www.ncbi.nlm.nih.gov/pubmed/21460621.
26. Choi S.L., et al. The regulation of AMP-activated protein kinase by H(2)O(2). Biochemistry Biophysics Research Communication 2001, 287(1):92-97. http://www.ncbi.nlm.nih.gov/pubmed/11549258, 10.1006/bbrc.2001.5544.
27. Chen Y., et al. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death and Differentiation 2008, 15(1):171-182. http://www.ncbi.nlm.nih.gov/pubmed/17917680, 10.1038/sj.cdd.4402233.
28. Djavaheri-Mergny M., et al. NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy. Journal of Biological Chemistry 2006, 281(41):30373-30382. http://www.ncbi.nlm.nih.gov/pubmed/16857678, 10.1074/jbc.M602097200.
29. Boyer-Guittaut M., et al. The role of GABARAPL1/GEC1 in autophagic flux and mitochondrial quality control in MDA-MB-436 breast cancer cells. Autophagy 2014, 10(6):986-1003. http://www.ncbi.nlm.nih.gov/pubmed/24879149, 10.4161/auto.28390.
30. Debnath J. The multifaceted roles of autophagy in tumors-implications for breast cancer. Journal of Mammary Gland Biology and Neoplasia 2011, 16(3):173-187. http://www.ncbi.nlm.nih.gov/pubmed/21779879, 10.1007/s10911-011-9223-3.
31. Morselli E., et al. Anti- and pro-tumor functions of autophagy. Biochimica et Biophysica Acta 2009, 1793(9):1524-1532. http://www.ncbi.nlm.nih.gov/pubmed/19371598, 10.1016/j.bbamcr.2009.01.006.
32. Zhang J., Ney P.A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death and Differentiation 2009, 16(7):939-946. http://www.ncbi.nlm.nih.gov/pubmed/19229244, 10.1038/cdd.2009.16.
33. Novak I. Mitophagy: a complex mechanism of mitochondrial removal. Antioxidants and Redox Signaling 2012, 17(5):794-802. http://www.ncbi.nlm.nih.gov/pubmed/22077334, 10.1089/ars.2011.4407.
34. Feng D., et al. Molecular signaling toward mitophagy and its physiological significance. Experimental Cell Research 2013, 319(12):1697-1705. http://www.ncbi.nlm.nih.gov/pubmed/23603281, 10.1016/j.yexcr.2013.03.034.
35. Youle R.J., Narendra D.P. Mechanisms of mitophagy. Nature Reviews Molecular Cell Biology 2011, 12(1):9-14. http://www.ncbi.nlm.nih.gov/pubmed/21179058, 10.1038/nrm3028.
36. Schweers R.L., et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proceedings of the National Academy of Sciences of the United States ofAmerica 2007, 104(49):19500-19505. http://www.ncbi.nlm.nih.gov/pubmed/18048346, 10.1073/pnas.0708818104.
37. Sandoval H., et al. Essential role for nix in autophagic maturation of erythroid cells. Nature 2008, 454(7201):232-235. http://www.ncbi.nlm.nih.gov/pubmed/18454133, 10.1038/nature07006.
38. Matsuda N., et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. Journal of Cell Biology 2010, 189(2):211-221.
39. Morselli E., et al. Oncosuppressive functions of autophagy. Antioxidants and Redox Signaling 2011, 14(11):2251-2269. http://www.ncbi.nlm.nih.gov/pubmed/20712403, 10.1089/ars.2010.3478.
40. Takamura A., et al. Autophagy-deficient mice develop multiple liver tumors. Genes & Development 2011, 25(8):795-800. 10.1101/gad.2016211.
41. Mathew R., et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes & Development 2007, 21(11):1367-1381. http://www.ncbi.nlm.nih.gov/pubmed/17510285, 10.1101/gad.1545107.
42. Karantza-Wadsworth V., et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes & Development 2007, 21(13):1621-1635.
43. Komatsu M., et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nature Cell Biology 2010, 12(3):213-223. http://www.ncbi.nlm.nih.gov/pubmed/20173742, 10.1038/ncb2021.
44. Lau A., et al. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Molecular and Cellular Biology 2010, 30(13):3275-3285. http://www.ncbi.nlm.nih.gov/pubmed/20421418, 10.1128/MCB.00248-10.
45. Taguchi K., et al. Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proceedings of the National Academy of Sciences of the United States ofAmerica 2012, 109(34):13561-13566. http://www.ncbi.nlm.nih.gov/pubmed/22872865, 10.1073/pnas.1121572109.
46. Villeneuve N.F., Lau A., Zhang D.D. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxidants and Redox Signaling 2010, 13(11):1699-1712. http://www.ncbi.nlm.nih.gov/pubmed/20486766, 10.1089/ars.2010.3211.
47. Sakurai T., et al. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 2008, 14(2):156-165. http://www.ncbi.nlm.nih.gov/pubmed/18691550, 10.1016/j.ccr.2008.06.016.
48. Brenner C., et al. Decoding cell death signals in liver inflammation. Journal of Hepatology 2013, 59(3):583-594. http://www.ncbi.nlm.nih.gov/pubmed/23567086, 10.1016/j.jhep.2013.03.033.
49. Saitoh T., Fujita N., Jang M.H., Uematsu S., Yang B.G., Satoh T., Omori H., Noda T., Yamamoto N., Komatsu M., Tanaka K., Kawai T., Tsujimura T., Takeuchi O., Yoshimori T., Akira S. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008, 456:264-268. http://www.ncbi.nlm.nih.gov/pubmed/18849965, 10.1038/nature07383.
50. Bensaad K., Cheung E.C., Vousden K.H. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO Journal 2009, 28(19):3015-3026. http://www.ncbi.nlm.nih.gov/pubmed/19713938, 10.1038/emboj.2009.242.
51. Nakahira K., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature Immunology 2011, 12(3):222-230. http://www.ncbi.nlm.nih.gov/pubmed/21151103, 10.1038/ni.1980.
52. Zhou R., et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469(7329):221-225. http://www.ncbi.nlm.nih.gov/pubmed/21124315, 10.1038/nature09663.
53. Roy D., Sarkar S., Felty Q. Levels of IL-1beta control stimulatory/inhibitory growth of cancer cells. Frontiers in Bioscience 2006, 11:889-898. http://www.ncbi.nlm.nih.gov/pubmed/16146780, 10.2741/1845.
54. Kang R., et al. HMGB1 in cancer: good, bad, or both?. Clinical Cancer Research 2013, 19(15):4046-4057. http://www.ncbi.nlm.nih.gov/pubmed/23723299, 10.1158/1078-0432.CCR-13-0495.
55. Tang D., et al. High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress. Antioxidants and Redox Signaling 2011, 15(8):2185-2195.
56. Mittal D., et al. TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO Journal 2010, 29(13):2242-2252. 10.1038/emboj.2010.94.
57. Lock R., et al. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Molecular Biology of the Cell 2011, 22(2):165-178. http://www.ncbi.nlm.nih.gov/pubmed/21119005, 10.1091/mbc.E10-06-0500.
58. Guo J.Y., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes & Development 2011, 25(5):460-470. http://www.ncbi.nlm.nih.gov/pubmed/21317241, 10.1101/gad.2016311.
59. Yang S., et al. Pancreatic cancers require autophagy for tumor growth. Genes & Development 2011, 25(7):717-729. 10.1101/gad.2016111.
60. Kim M.J., et al. Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation. Journal of Biological Chemistry 2011, 286(15):12924-12932. http://www.ncbi.nlm.nih.gov/pubmed/21300795, 10.1074/jbc.M110.138958.
61. Weinberg F., et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proceedings of the National Academy of Sciences of the United States ofAmerica 2010, 107(19):8788-8793. http://www.ncbi.nlm.nih.gov/pubmed/20421486, 10.1073/pnas.1003428107.
62. Strohecker A.M., et al. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discovery 2013, 3(11):1272-1285. http://www.ncbi.nlm.nih.gov/pubmed/23965987, 10.1158/2159-8290.CD-13-0397.
63. Guo J.Y., et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes & Development 2013, 27(13):1447-1461. http://www.ncbi.nlm.nih.gov/pubmed/23824538, 10.1101/gad.219642.113.
64. Degenhardt K., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10(1):51-64. http://www.ncbi.nlm.nih.gov/pubmed/16843265, 10.1016/j.ccr.2006.06.001.
65. Duran A., et al. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 2008, 13(4):343-354. http://www.ncbi.nlm.nih.gov/pubmed/18394557, 10.1016/j.ccr.2008.02.001.
66. Mathew R., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137(6):1062-1075. http://www.ncbi.nlm.nih.gov/pubmed/19524509, 10.1016/j.cell.2009.03.048.
67. Wei H., et al. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes & Development 2011, 25(14):1510-1527. http://www.ncbi.nlm.nih.gov/pubmed/21764854, 10.1101/gad.2051011.
68. Harris A.L. Hypoxia -a key regulatory factor in tumour growth. Nature Reviews Cancer 2002, 2(1):38-47. http://www.ncbi.nlm.nih.gov/pubmed/11902584, 10.1038/nrc704.
69. Brahimi-Horn M.C., Bellot G., Pouysségur J. Hypoxia and energetic tumour metabolism. Current Opinion in Genetics and Development 2011, 21(1):67-72. http://www.ncbi.nlm.nih.gov/pubmed/21074987, 10.1016/j.gde.2010.10.006.
70. 2 sensing. Journal of Biological Chemistry 2000, 275(33):25130-25138. 10.1074/jbc.M001914200.
71. Zhang H., et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. Journal of Biological Chemistry 2008, 283(16):10892-10903. http://www.ncbi.nlm.nih.gov/pubmed/18281291, 10.1074/jbc.M800102200.
72. Bellot G., et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Molecular and Cellular Biology 2009, 29(10):2570-2581. http://www.ncbi.nlm.nih.gov/pubmed/19273585, 10.1128/MCB.00166-09.
73. Rouschop K.M., et al. Autophagy is required during cycling hypoxia to lower production of reactive oxygen species. Radiotherapy and Oncology 2009, 92(3):411-416. http://www.ncbi.nlm.nih.gov/pubmed/19616335, 10.1016/j.radonc.2009.06.029.
74. Mazure N.M., Pouysségur J. Hypoxia-induced autophagy: cell death or cell survival?. Current Opinion in Cell Biology 2010, 22(2):177-180. http://www.ncbi.nlm.nih.gov/pubmed/20022734, 10.1016/j.ceb.2009.11.015.
75. Papandreou I., et al. Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. Cell Death and Differentiation 2008, 15(10):1572-1581. http://www.ncbi.nlm.nih.gov/pubmed/18551130, 10.1038/cdd.2008.84.
76. Rouschop K.M., et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. Journal of Clinical Investigation 2010, 120(1):127-141. http://www.ncbi.nlm.nih.gov/pubmed/20038797, 10.1172/JCI40027.
77. Rabinowitz J.D., White E. Autophagy and metabolism. Science 2010, 330(6009):1344-1348. http://www.ncbi.nlm.nih.gov/pubmed/21127245, 10.1126/science.1193497.
78. Eng C.H., Abraham R.T. The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming. Oncogene 2011, 30(47):4687-4696. http://www.ncbi.nlm.nih.gov/pubmed/21666712, 10.1038/onc.2011.220.
79. Sethi N., Kang Y. Unravelling the complexity of metastasis -molecular understanding and targeted therapies. Nature Reviews Cancer 2011, 11(10):735-748. http://www.ncbi.nlm.nih.gov/pubmed/21941285, 10.1038/nrc3125.
80. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147(2):275-292. http://www.ncbi.nlm.nih.gov/pubmed/22000009, 10.1016/j.cell.2011.09.024.
81. Lamouille S., Xu J., Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nature Reviews Molecular Cell Biology 2014, 15(3):178-196. http://www.ncbi.nlm.nih.gov/pubmed/24556840, 10.1038/nrm3758.
82. Lazova R., Camp R.L., Klump V., Siddiqui S.F., Amaravadi R.K., Pawelek J.M. Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clinical Cancer Research 2012, 18:370-379. http://www.ncbi.nlm.nih.gov/pubmed/22080440, 10.1158/1078-0432.CCR-11-1282.
83. Ma X.H., et al. Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clinical Cancer Research 2011, 17(10):3478-3489. http://www.ncbi.nlm.nih.gov/pubmed/21325076, 10.1158/1078-0432.CCR-10-2372.
84. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147(5):992-1009. http://www.ncbi.nlm.nih.gov/pubmed/22118458, 10.1016/j.cell.2011.11.016.
85. Reymond N., d'Agua B.B., Ridley A.J. Crossing the endothelial barrier during metastasis. Nature Reviews Cancer 2013, 13(12):858-870.
86. Fung C., et al. Induction of autophagy during extracellular matrix detachment promotes cell survival. Biochimica et Biophysica Acta 2008, 19(3):797-806. http://www.ncbi.nlm.nih.gov/pubmed/18094039, 10.1091/mbc.E07-10-1092.
87. Paoli P., Giannoni E., Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochimica et Biophysica Acta 2013, 1833(12):3481-3498. http://www.ncbi.nlm.nih.gov/pubmed/23830918, 10.1016/j.bbamcr.2013.06.026.
88. Peng Y.F., et al. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy 2013, 9(12):2056-2068. http://www.ncbi.nlm.nih.gov/pubmed/24157892, 10.4161/auto.26398.
89. Avivar-Valderas A., et al. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene 2013, 32(41):4932-4940. http://www.ncbi.nlm.nih.gov/pubmed/23160380, 10.1038/onc.2012.512.
90. Buchheit C.L., Rayavarapu R.R., Schafer Z.T. The regulation of cancer cell death and metabolism by extracellular matrix attachment. Seminars in Cell and Developmental Biology 2012, 23(4):402-411. http://www.ncbi.nlm.nih.gov/pubmed/22579674, 10.1016/j.semcdb.2012.04.007.
91. Avivar-Valderas A., et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Molecular and Cellular Biology 2011, 31(17):3616-3629. 10.1128/MCB.05164-11.
92. Macintosh R.L., et al. Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle 2012, 11(10):2022-2029.
93. Galavotti S., et al. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene 2013, 32(6):699-712. http://www.ncbi.nlm.nih.gov/pubmed/22525272, 10.1038/onc.2012.111.
94. Li J., et al. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Carcinogenesis 2013, 34(6):1343-1351. http://www.ncbi.nlm.nih.gov/pubmed/23430956, 10.1093/carcin/bgt063.
95. Kenific C.M., Thorburn A., Debnath J. Autophagy and metastasis: another double-edged sword. Current Opinion in Cell Biology 2010, 22(2):241-245. http://www.ncbi.nlm.nih.gov/pubmed/19945838, 10.1016/j.ceb.2009.10.008.
96. DeNardo D.G., Johansson M., Coussens L.M. Immune cells as mediators of solid tumor metastasis. Cancer and Metastasis Reviews 2008, 27(1):11-18. http://www.ncbi.nlm.nih.gov/pubmed/18066650, 10.1007/s10555-007-9100-0.
97. Tlsty T.D., Coussens L.M. Tumor stroma and regulation of cancer development. Annual Review of Pathology 2006, 1:119-150. http://www.ncbi.nlm.nih.gov/pubmed/18039110, 10.1146/annurev.pathol.1.110304.100224.
98. Lv Q., Wang W., Xue J., Hua F., Mu R., Lin H., Yan J., Lv X., Chen X., Hu Z.W. DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial-mesenchymal transition in human breast cancer. Cancer Research 2012, 72:3238-3250. http://www.ncbi.nlm.nih.gov/pubmed/22719072, 10.1158/0008-5472.CAN-11-3832.
99. Wang M.C., et al. In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non-small cell lung cancer cell lines. Oncology Reports 2015, 33(1):239-249. http://www.ncbi.nlm.nih.gov/pubmed/25370413, 10.3892/or.2014.3583.
100. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407(6801):249-257. http://www.ncbi.nlm.nih.gov/pubmed/11001068, 10.1038/35025220.
101. Nguyen T.M., et al. Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells. Blood 2007, 109(11):4793-4802. http://www.ncbi.nlm.nih.gov/pubmed/17272502, 10.1182/blood-2006-11-059352.
102. Ramakrishnan S., et al. Autophagy and angiogenesis inhibition. Autophagy 2007, 3(5):512-515. http://www.ncbi.nlm.nih.gov/pubmed/17643071, 10.4161/auto.4734.
103. Shen W., et al. Oxidative stress mediates chemerin-induced autophagy in endothelial cells. Free Radical Biology and Medicine 2013, 55:73-82. http://www.ncbi.nlm.nih.gov/pubmed/23195684, 10.1016/j.freeradbiomed.2012.11.011.
104. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nature Reviews Cancer 2006, 6(5):392-401. http://www.ncbi.nlm.nih.gov/pubmed/16572188, 10.1038/nrc1877.
105. Maes H., et al. Autophagy: shaping the tumor microenvironment and therapeutic response. Trends in Molecular Medicine 2013, 19(7):428-446. http://www.ncbi.nlm.nih.gov/pubmed/23714574, 10.1016/j.molmed.2013.04.005.
106. Martinez-Outschoorn U.E., et al. The autophagic tumor stroma model of cancer or "battery-operated tumor growth": a simple solution to the autophagy paradox. Cell Cycle 2010, 9(21):4297-4306.
107. Martinez-Outschoorn U.E., et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010, 9(16):3256-3276. http://www.ncbi.nlm.nih.gov/pubmed/20814239, 10.4161/cc.9.16.12553.
108. Pavlides S., et al. The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 2010, 9(17):3485-3505.
109. Martinez-Outschoorn U.E., et al. Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle 2011, 10(11):1784-1793. http://www.ncbi.nlm.nih.gov/pubmed/21566463.
110. Sotgia F., et al. Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annual Review of Pathology 2012, 7:423-467. http://www.ncbi.nlm.nih.gov/pubmed/22077552, 10.1146/annurev-pathol-011811-120856.
111. Martinez-Outschoorn U.E., et al. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. International Journal of Biochemistry & Cell Biology 2011, 43(7):1045-1051. 10.1016/j.biocel.2011.01.023.
112. Bensaad K., et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126(1):107-120. http://www.ncbi.nlm.nih.gov/pubmed/16839880, 10.1016/j.cell.2006.05.036.
113. Lisanti M.P., et al. Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment. Cancer Biology & Therapy 2010, 10(6):537-542.
114. Zhao X., He Y., Chen H. Autophagic tumor stroma: mechanisms and roles in tumor growth and progression. International Journal of Cancer 2013, 132(1):1-8. http://www.ncbi.nlm.nih.gov/pubmed/22684793, 10.1002/ijc.27664.
115. Pavlides S., et al. Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxidants and Redox Signaling 2012, 16(11):1264-1284. http://www.ncbi.nlm.nih.gov/pubmed/21883043, 10.1089/ars.2011.4243.
116. Martinez-Outschoorn U.E., et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle 2010, 9(17):3515-3533.
117. Bonuccelli G., et al. Ketones and lactate "fuel" tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010, 9(17):3506-3514.
118. Iozzo R.V. Autophagic tumor stroma: a biofuel for cancer growth. Cell Cycle 2011, 10(19):3231-3232. http://www.ncbi.nlm.nih.gov/pubmed/21946523, 10.4161/cc.10.19.17124.
119. Castello-Cros R., et al. Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis. Cell Cycle 2011, 10(12):2021-2034. http://www.ncbi.nlm.nih.gov/pubmed/21646868, 10.4161/cc.10.12.16002.
120. Sotgia F., et al. Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells. Cell Cycle 2012, 11(23):4390-4401. 10.4161/cc.22777.
121. Carew J.S., Kelly K.R., Nawrocki S.T. Autophagy as a target for cancer therapy: new developments. Cancer Management and Research 2012, 4:357-365. http://www.ncbi.nlm.nih.gov/pubmed/23091399, 10.2147/CMAR.S26133.
122. Zhou H., et al. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway. Oncotarget 2014, 5:10140-10150. http://www.ncbi.nlm.nih.gov/pubmed/25294812.
123. Hahm E.R., Sakao K., Singh S.V. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells. Prostate 2014, 74(12):1209-1221. http://www.ncbi.nlm.nih.gov/pubmed/25043291, 10.1002/pros.22837.
124. Gonzalez Y., et al. Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress. Oncotarget 2014, 5(6):1526-1537. http://www.ncbi.nlm.nih.gov/pubmed/24681637.
125. Kim H., et al. Quercetin induces mitochondrial mediated apoptosis and protective autophagy in human glioblastoma U373MG cells. Oxidative Medicine and Cellular Longevity 2013, 2013:596496. http://www.ncbi.nlm.nih.gov/pubmed/24379902, 10.1155/2013/596496.
126. Zhang Q., et al. Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells. Genes Cancer 2014, 5(3-4):100-112. http://www.ncbi.nlm.nih.gov/pubmed/25053988.
127. Al Dhaheri Y., et al. Carnosol induces ROS-Mediated Beclin1-Independent autophagy and apoptosis in triple negative breast cancer. PLOS One 2014, 9(10):e109630. http://www.ncbi.nlm.nih.gov/pubmed/25299698, 10.1371/journal.pone.0109630.
128. Hao W., et al. Psoralidin induces autophagy through ROS generation which inhibits the proliferation of human lung cancer A549 cells. PeerJ 2014, 2:e555. http://www.ncbi.nlm.nih.gov/pubmed/25250213, 10.7717/peerj.555.
129. Miki H., et al. Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. International Journal of Oncology 2012, 40(4):1020-1028. http://www.ncbi.nlm.nih.gov/pubmed/22218562, 10.3892/ijo.2012.1325.
130. Winterbourn C.C. The challenges of using fluorescent probes to detect and quantify specific reactive oxygen species in living cells. Biochimica et Biophysica Acta 2014, 1840(2):730-738. http://www.ncbi.nlm.nih.gov/pubmed/23665586, 10.1016/j.bbagen.2013.05.004.
131. La Favor J.D., Anderson E.J., Hickner R.C. Novel method for detection of reactive oxygen species in vivo in human skeletal muscle. Physiological Research 2014, 63(3):387-392. http://www.ncbi.nlm.nih.gov/pubmed/24564604.
132. Mrakic-Sposta S., et al. Assessment of a standardized ROS production profile in humans by electron paramagnetic resonance. Oxidative Medicine and Cellular Longevity 2012, 2012:973927. http://www.ncbi.nlm.nih.gov/pubmed/22900129, 10.1155/2012/973927.
133. Roberts L.J., Moore K.P., Zackert W.E., Oates J.A., Morrow J.D. Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans. Journal of Biological Chemistry 1996, 271:20617-20620. http://www.ncbi.nlm.nih.gov/pubmed/8702808, 10.1074/jbc.271.34.20617.
134. Smith G., Nguyen Q.D., Aboagye E.O. Translational imaging of apoptosis. Anti-Cancer Agents in Medicinal Chemistry 2009, 9(9):958-967. http://www.ncbi.nlm.nih.gov/pubmed/19663785.
135. Klionsky D.J., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8(4):445-544.